Glucoguard’s advanced AI algorithm can anticipate anticipate low sugar (hypoglycemic episode) before it occurs, enabling proactive treatment to prevent it from happening.
If a certain threshold is reached or if the values are trending downward too quickly, GlucoGuard will activate and administer glucose over a time frame of 5 minutes. The device will then continue to monitor if the hypoglycemic episode has been corrected. If the low is corrected our device will
continue to monitor the blood sugar levels.
This analysis continues throughout the sleeping period. If the user is within an acceptable range, there is
no treatment and the process repeats. If the blood sugar level falls out of the primary and secondary
thresholds, the device then examines the trend rate. If the rate exceeds the tolerance allowed by
GlucoGuard, it will administer glucose and enter high alert mode. If the blood sugar
level registers below 70 mg/dL, the device automatically administers glucose,
enters high alert mode and repeats the cycle.